Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Omalizumab: a potential new therapeutic approach for aspirin-exacerbated respiratory disease.

× No keyword cloud information.

8 in total

Review 1. Off-Label Uses of Omalizumab.

Authors: David El-Qutob
Journal: Clin Rev Allergy Immunol Date: 2016-02 Impact factor: 8.667

Review 2. Update on Aspirin-Exacerbated Respiratory Disease.

Authors: Katharine M Woessner
Journal: Curr Allergy Asthma Rep Date: 2017-01 Impact factor: 4.806

Review 3. Human(ized) monoclonal antibodies in atopic patients - state of the art.

Authors: Arzu Didem Yalcin; Kevser Onbasi; Rusen Uzun; Felix Herth; Philipp Albert Schnabel
Journal: Cent Eur J Immunol Date: 2020-07-27 Impact factor: 2.085

4. Omalizumab, an anti-immunoglobulin E antibody: state of the art.

Authors: Cristoforo Incorvaia; Marina Mauro; Marina Russello; Chiara Formigoni; Gian Galeazzo Riario-Sforza; Erminia Ridolo
Journal: Drug Des Devel Ther Date: 2014-02-07 Impact factor: 4.162

Review 5. Update on the Management of Aspirin-Exacerbated Respiratory Disease.

Authors: Kathleen M Buchheit; Tanya M Laidlaw
Journal: Allergy Asthma Immunol Res Date: 2016-07 Impact factor: 5.764

Review 6. Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advances.

Authors: John W Steinke; Jeff M Wilson
Journal: J Asthma Allergy Date: 2016-03-10

Review 7. Anti-IgE Treatment for Disorders Other Than Asthma.

Authors: Jeffrey Stokes
Journal: Front Med (Lausanne) Date: 2017-09-21

8. Clinical Significance of Cytoplasmic IgE-Positive Mast Cells in Eosinophilic Chronic Rhinosinusitis.

Authors: Yuka Gion; Mitsuhiro Okano; Takahisa Koyama; Tokie Oura; Asami Nishikori; Yorihisa Orita; Tomoyasu Tachibana; Hidenori Marunaka; Takuma Makino; Kazunori Nishizaki; Yasuharu Sato
Journal: Int J Mol Sci Date: 2020-03-07 Impact factor: 5.923

8 in total